Down but not out: MannKind sees positive in Sanofi’s Afrezza exit
Sanofi has abandoned Afrezza less than a year after its launch, but the future of the inhaled insulin product is secure according to developer MannKind.
Archives for January 6, 2016
CTMS market set to hit $2bn by 2019 yet CROs may not be the driver
The global clinical trial management system (CTMS) market is expected to grow 14% over a five-year period hitting an almost $2bn valuation by 2019, according to a new market report.
Bad data: new methods needed to catch errors in clinical trials
About 2% of researchers admit to data manipulation, but this figure may be much higher and a new method is being sought to detect flawed data.
AstraZeneca's purple reign? Dr Reddy's relaunches Nexium generic in blue
Dr Reddy’s has changed the colour of its Nexium generic capsules from purple to blue in a bid to resume US sales, as litigation with AstraZeneca continues.
Kalbe Farma to build Indonesian facility to tackle import challenges
Kalbe Farma has launched construction plans for a local raw materials facility in a bid to tackle import challenges.
Merck expands deal with 'organ-on-chip' tech firm Emulate
Merck & Co. has expanded a partnership to use Emulate’s organ-on-chip technology to carry out predictive modelling of inflammatory processes.